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Recent Developments in Surgery
Minimally Invasive Approaches for Patients
Requiring Pancreaticoduodenectomy
Scott A. Zenoni, MD; J. Pablo Arnoletti, MD; Sebastian G. de la Fuente, MD
A pancreaticoduodenectomy (PD) has been universallyaccepted as the only chance for cure for patientswith cancerous tumors on the head of the pancreas,
distal common bile duct tumors, and periampullary
malignant tumors. Since first described by Alessandro
Codivilla in 18981 and later popularized by Whipple et al2
in 1935, significant improvements have been achieved in
the preoperative, intraoperative, and postoperative man-
agement of patients with pancreatic cancers, resulting in
decreased morbidity and mortality rates when surgical
procedures are performed at high-volume institutions.3
These advances have allowed surgeons to explore less
invasive alternative techniques with the intention of obtain-
ing faster recovery times while maintaining sound oncologic
outcomes.4-6 Over the last several years, the introduction
of minimally invasive techniques and robotic systems to
the field of surgical oncology has allowed for improved
visualization of the surgical field with precise manipulation
of delicate tissues. For patients with pancreatic cancer,
this is of paramount importance because an increasing
number of patients undergo neoadjuvant therapy prior
to surgical resection, which makes the distinction of normal
dissection planes challenging. To date, only a handful
of institutions have retrospectively reported their ex-
perience with laparoscopic and robotic PD (Table), with con-
flicting results. With this background, the purpose of our
study is to review the current data available on minimally
invasive PD.
First Reports of Laparoscopic PD
Laparoscopic PD was first reported in 1994 by Gagner and
Pomp4 in a young patientwith chronic pancreatitis frompan-
creasdivisum.Since then, a growingnumberof surgeonshave
published their early experiencewith theseprocedures.5,6,11-13
These early studies mainly focused on the feasibility of the
technique and on early postoperative outcomes. In general,
early data show outcomes similar to those with open tech-
niques,with faster recovery times as evidencedby shorter in-
tensive careunit andoverall hospital stays.A recent reviewby
Gumbs et al14 published in 2011 found 27 articles comprising
285 cases of laparoscopic PD, including 13% of hand-assisted
cases. In this extensive review,14 the rate of conversion to an
openapproachwas9%,with aweightedaverage lengthof stay
of 12 days and a morbidity rate of 48%. Based on these find-
ings,Gumbsetal14concludedthat laparoscopicpancreatichead
resections are not only feasible but also safe, with low mor-
tality rates andacceptable complication rates.Theauthors fur-
ther emphasized the lack of long-term follow-updata and the
relatively small number of studies comparing minimally in-
vasive techniques with open techniques.14
Over the past decade, minimally invasive surgery has been introduced as a means to allow
manipulation of delicate tissues with outstanding visualization of the surgical field. The
purpose of this article is to review the available literature regarding early postoperative
outcomes and the technical challenges of minimally invasive pancreaticoduodenectomy,
including robotic techniques. Herein, we provide a retrospective review of all published
studies in the English literature in which a minimally invasive pancreaticoduodenectomy
was performed. The reported advantages of minimally invasive pancreaticoduodenectomy
include better visualization, faster recovery time, and decreased length of hospital stay. In
cases of robotic approaches, some of the proposed advantages include increased dexterity
and a superior ergonomic position for the operating surgeon. To our knowledge, few studies
have reported results comparable to open techniques in oncologic outcomes with regard to
the number of lymph nodes resected and clear margins obtained. An increasing number of
pancreatic resections are being performed using minimally invasive approaches. It remains to
be determined if the benefits of this technique outweigh its longer operative times and
higher costs.
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Comparison of Techniques:
Laparoscopic vs Open PD
With the increasing number of surgeons rapidly gaining
experience in complex laparoscopic pancreatic techniques,
the first reports of comparative studies have recently been
published.9,11,15 In a retrospective review of 51 consecutive
patients who underwent either an open or a laparoscopic
PD, Kuroki and colleagues15 found decreased blood loss in
the laparoscopy-assisted PD group compared with the open
PD group. Furthermore, these investigators found no sig-
nificant differences in the occurrence of postoperative com-
plications between the 2 groups.15 To our knowledge,
Asburn and Stauffer11 recently published the largest com-
parative study of more than 260 patients, 53 of whom
underwent a laparoscopic PD. Intraoperative and postopera-
tive factors in favor of a laparoscopic approach included
decreased blood loss, shorter lengths of hospital stay and
intensive care unit stay, transfusion requirements, and
greater number of lymph nodes retrieved at the time of the
operation. Importantly, no differences were noted in the
rate of early postoperative morbidity or mortality. As
expected, operative times were significantly longer for lapa-
roscopic cases, with a mean (SD) time per case of 541 (88)
minutes (9 hours).
Theoretical Advantages of Robotic-Assisted PD
It is generally accepted that the use of robotic systems pro-
vides improved visualization with 3-dimensional imaging
and improved movement of instrumentation in limited
spaces and ensures better ergonomics for the operating
surgeon16 (Box). These observations arose from a series of
retrospective studies describing the first experiences using
robotics for PD. Giulianotti and colleagues7 reported in 2010
the first series of 50 patients who underwent robotic-
assisted PD in Italy and the United States. In this retrospec-
tive study, the median operative time was 421 minutes
(range, 240-660 minutes), with a median blood loss of 394
cm3 (range, 80-1500 cm3). The length of stay significantly
varied depending on the location. In the Italian group, the
mean length of stay was 28.7 days, whereas in the US group,
the mean length of stay was 12.5 days. In this series,7
6 patients had a grade A fistula postoperatively, 5 patients
had a grade B fistula postoperatively, and 1 patient had a
grade C fistula postoperatively. More recently, in a single-
institution retrospective review, Zureikat and colleagues17
reported on 24 patients who underwent a robotic-assisted
nonpylorus-preserving PD at the University of Pittsburgh in
Pennsylvania. The median operative time in this study17
was 512 minutes (range, 327-848 minutes), with a median
blood loss of 320 cm3 (range, 50-1000 cm3) and a median
length of stay of 9 days (range, 4-87 days). The overall pan-
creatic fistula rate was 27% (n = 8). Clavien grade III and
grade IV complications occurred in 7 patients (23%),
whereas Clavien grade I and grade II complications occurred
in 27% of patients.
Box. Proposed Advantages of 2 Different Types
of Pancreaticoduodenectomy (PD)
Advantages ofMinimally Invasive PD
Decreased blood loss, resulting in less transfusions
Shorter hospital stays
Shorter intensive care unit stays
Superior cosmetics
Advantages of Robotic-Assisted PD
Improved 3-dimensional imaging
Enhanced dexterity
Better visualization, increasedmagnification
Improved ergonomics
Table. Current Studies Available on Robotic-Assisted Pancreaticoduodenectomy
Source, y
Patients,
No.
Median (Range) or Mean (SD)
Pathology
Data
Leak
Rate,
%
Complication
Rate, %
Operative
Times, min
Estimated
Blood Loss, mL
Length
of Stay, d
Giulianotti
et al,7 2001a
50 421 (240-660) 394 (80-1500) 22 (5-85) Positive margin rate of
0% in Italy and 21% in
US; 21 and 15 mean
lymph nodes
harvested in Italy and
US, respectively
31.3 Did not discriminate
among complications
based on surgical
approach
Zureikat
et al,5 2011
30 512 (327-848) 320 (50-1000) 9 (4-87) Not available 27 27 (Clavien grade I and
grade II), 23 (Clavien
grade III and grade IV)
Zhou et al,8
2011
8 718 (186) 153 (43) 16.4 (4.1) R0 resection rate of
100%
50 25
Chalikonda
et al,9 2012
30 476 (363-727) 485 (50-3500) 9.79 Mean tumor diameter
of 2.9 cm
13 30
Buchs et al,10
2010b
42 Older, 420 (62);
younger, 443.8 (9)
Older, 388 (282);
younger, 390 (379)
Older, 14.3 (8.3);
younger, 11.2 (4.8)
Not available 19.5 39
a Patients were from Italy and the United States (US).
b Comparing 2 groups of patients undergoing robotic-assisted pancreaticoduodenectomy (patients <70 years vs patients70 years).
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Other investigators have compared robotic-assisted PD
with open PD. Zhou et al8 reported on 16 patients who had
no significant difference in negative margin rates but had
lower rates of blood loss, lower complications rates, and
decreased lengths of stay with robotic-assisted PD. The low
number of patients in this study8 prohibits any meaningful
statistical analysis. A larger study by Chalikonda and
colleagues9 compared 30 patients undergoing robotic-
assisted PD with 30 patients undergoing open PD; both
groups had similar demographic characteristics and surgical
indications. Operative times were significantly longer in the
robotic-assisted group, but their overall blood loss was
lower. The mean lengths of stay were significantly different
between groups (9.79 days for the robotic-assisted group vs
13.26 days for the open group; P = .04). Based on these lim-
ited data, both studies8,9 concluded that robotic-assisted PD
might be associated with faster recovery times but longer
operative times.
With regard to immediate oncologic outcomes, Zeh et
al18 reported on 50 consecutives patients who underwent a
robotic-assisted PD (36 underwent a classic PD, and 14
underwent a pylorus-preserving PD). The median tumor
size was 2.5 cm, with a mean (SD) of 17 (7) lymph nodes
retrieved. For these patients, the overall margin-negative
(R0) resection rate was 89%. Importantly, 11 of the
15 patients who met the criteria for adjuvant therapy
were treated at a mean follow-up of 11.5 weeks postopera-
tively.
Current Limitations
The main limitations of robotic procedures are related to the
high costs associated with the purchase of the robotic sys-
tem and disposable equipment19 and the steep learning
curve associated with the technique. To date, studies com-
paring the cost-effectiveness of robotic-assisted PD or mini-
mally invasive PD with the cost-effectiveness of open PD
have not been conducted.
As with other complex operations, there is a lack of
data regarding the recommended number of procedures a
surgeon should perform before attempting robotic-assisted
PD. Undoubtedly, prior extensive experience in hepatopan-
creatobiliary surgery is mandatory, and training in mini-
mally invasive PD is typically recommended. Proctored test-
ing tailored to the curriculum is often required by
credentialing departments before establishing a new
program.20
Conclusions
Minimally invasive techniques provide some benefits to
patients requiring a PD. The robotic systems currently avail-
able are not hindered by some of the limitations that plague
laparoscopic techniques, such as a limited range of motion,
a 2-dimensional visualization of the surgical field, and poor
ergonomics for surgeons. For example, the ability of the
system to compensate for natural tremors may allow for a
more precise technique when a delicate anastomosis
is constructed.10 However, it is intriguing that the avail-
able data on minimally invasive techniques have failed
to demonstrate improvements in outcomes, such as leak
rates and conversion rates, compared with the outcomes
associated with laparoscopic techniques. The need for a lon-
ger learning curve might serve to explain some of these
issues.
Currently, data on oncologic outcomes have been lim-
ited to a few retrospective reports, and there is a lack of lit-
erature investigating the financial implications of this
approach. The need for cost-effective approaches that could
potentially provide similar or better early and late results is
essential in times of financial difficulties. Although shorter
hospital stays are certainly appealing, based on currently
available data, the faster recovery times associated with
minimally invasive approaches have not resulted in adju-
vant chemotherapy being initiated sooner. From the per-
spective of general surgery residents, it is imperative to
understand that only after rigorous unbiased examination
could minimally invasive PD potentially become a valid tool
in the armamentarium of surgeons for treating pancreatic
cancer.
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